IT 901
CAS: 1584121-99-2
Ref. 3D-JNC12199
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Product Information
IT 901 is a combination strategy that targets the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). It is an orally administered drug that has been shown to be effective in cancer treatment. This drug has been shown to target chronic lymphocytic leukemia cells and leukemia cells, which are activated due to constitutive activation of NF-κB. IT901 also inhibits proliferation of leukemia cells by modulating the microenvironment, which may be due to its ability to induce apoptosis.
Chemical properties
Technical inquiry about: 3D-JNC12199 IT 901
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.